These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1678917)

  • 21. Comparison of pharmacokinetics and pharmacodynamics of adrenoceptor agonists and antagonists as antihypertensive agents.
    Louis WJ; McNeil JJ; Anavekar SN; Conway EL; Workman B; Howes LG; Drummer OH; Jarrott B
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S100-3. PubMed ID: 2455158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Progress in the studies of alpha1-adrenoceptor blocker for concurrent benign prostatic hyperplasia and hypertension].
    Yang MG; Zhao XK
    Zhonghua Nan Ke Xue; 2007 Sep; 13(9):830-4. PubMed ID: 17929564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The usefulness of alpha-adrenoceptor blockade in the treatment of hypertension.
    Warren JB; Dollery CT
    J Hypertens Suppl; 1988 Dec; 6(2):S43-9. PubMed ID: 2906700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hytrin treatment of hypertension and benign prostatic hyperplasia.
    Moon L; Pfettscher S
    ANNA J; 1995 Jun; 22(3):335-6. PubMed ID: 7540385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Reduction of coronary risk factors with selective alpha-blockers. International Doxazosin Symposium. Frankfurt/Main, 7 June 1986].
    Fortschr Med Suppl; 1986; 8():1-19. PubMed ID: 2876941
    [No Abstract]   [Full Text] [Related]  

  • 26. Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension.
    Titmarsh S; Monk JP
    Drugs; 1987 May; 33(5):461-77. PubMed ID: 2885169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertension, lipids and alpha-blockade. Proceedings of an international symposium. Paris, France, 27 May, 1989.
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():1-94. PubMed ID: 2575175
    [No Abstract]   [Full Text] [Related]  

  • 28. [The effect of terazosin and nitrendipine on blood insulin, glucose and lipid in SHR rats].
    Wang W
    Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Aug; 21(4):234-5. PubMed ID: 7910793
    [No Abstract]   [Full Text] [Related]  

  • 29. Adrenergic mechanisms in left ventricular hypertrophy: significance and clinical implications.
    Ram CV
    J Clin Pharmacol; 1993 Sep; 33(9):887-91. PubMed ID: 7901244
    [No Abstract]   [Full Text] [Related]  

  • 30. [Circadian rise of blood pressure and combined alpha-beta adrenoceptor blockade].
    Rietbrock N; Woodcock BG
    Dtsch Med Wochenschr; 1985 Mar; 110(10):388-91. PubMed ID: 2857634
    [No Abstract]   [Full Text] [Related]  

  • 31. Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension.
    Young RA; Brogden RN
    Drugs; 1988 May; 35(5):525-41. PubMed ID: 2899495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The value of alpha-blockers in the management of hypertension: a practical view.
    McInnes GT
    J Hum Hypertens; 1991 Aug; 5(4):313-6. PubMed ID: 1683406
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of alpha 1-blockade in benign prostatic hyperplasia.
    Brawer MK
    J Clin Pharmacol; 1993 Sep; 33(9):891-5. PubMed ID: 7693769
    [No Abstract]   [Full Text] [Related]  

  • 34. [Diurnal blood-pressure profile under Polypress therapy].
    Kirchhoff HW
    MMW Munch Med Wochenschr; 1982 Jul; 124(29-30):679-81. PubMed ID: 6126809
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of enalapril and terazosin on lipid metabolism in patients with essential arterial hypertension and accompanying hypercholesterolemia].
    Ponikowski P; Hańczycowa H; Sebzda T; Jurga M; Spring A; Rotter A; Jordanek P
    Wiad Lek; 1993 Apr; 46(7-8):250-4. PubMed ID: 7902632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of alpha-adrenoceptor blockade in the treatment of hypertension.
    Abrams SM; Turner P
    J Clin Hosp Pharm; 1983 Jun; 8(2):175-81. PubMed ID: 6135715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of the use of alpha-adrenoceptor antagonists in hypertension.
    Stokes GS; Marwood JF
    Methods Find Exp Clin Pharmacol; 1984 Apr; 6(4):197-204. PubMed ID: 6146746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular effects of short-term selective alpha 1-adrenergic blockade with terazosin in patients with essential hypertension.
    Beretta-Piccoli C; Ferrier C; Weidmann P
    J Hypertens Suppl; 1985 Dec; 3(3):S231-4. PubMed ID: 2908818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Alpha-1 inhibition and blood pressure regulation].
    Drici MD
    Ann Cardiol Angeiol (Paris); 1990 Dec; 39(10 ( Pt 2)):629-30. PubMed ID: 1983165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood pressure and lipid lowering effects of terazosin.
    Rosenthal J
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():85-9; discussion 90-1. PubMed ID: 2575179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.